Literature DB >> 25749248

Vaccines, our shared responsibility.

Sonia Pagliusi1, Rishabh Jain2, Rajinder Kumar Suri3.   

Abstract

The Developing Countries Vaccine Manufacturers' Network (DCVMN) held its fifteenth annual meeting from October 27-29, 2014, New Delhi, India. The DCVMN, together with the co-organizing institution Panacea Biotec, welcomed over 240 delegates representing high-profile governmental and nongovernmental global health organizations from 36 countries. Over the three-day meeting, attendees exchanged information about their efforts to achieve their shared goal of preventing death and disability from known and emerging infectious diseases. Special praise was extended to all stakeholders involved in the success of polio eradication in South East Asia and highlighted challenges in vaccine supply for measles-rubella immunization over the coming decades. Innovative vaccines and vaccine delivery technologies indicated creative solutions for achieving global immunization goals. Discussions were focused on three major themes including regulatory challenges for developing countries that may be overcome with better communication; global collaborations and partnerships for leveraging investments and enable uninterrupted supply of affordable and suitable vaccines; and leading innovation in vaccines difficult to develop, such as dengue, Chikungunya, typhoid-conjugated and EV71, and needle-free technologies that may speed up vaccine delivery. Moving further into the Decade of Vaccines, participants renewed their commitment to shared responsibility toward a world free of vaccine-preventable diseases.
Copyright © 2015 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Collaboration; Developing countries; Immunization; Innovation; Vaccines

Mesh:

Substances:

Year:  2015        PMID: 25749248     DOI: 10.1016/j.vaccine.2015.02.065

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  3 in total

1.  Chlamydomonas reinhardtii chloroplasts express an orally immunogenic protein targeting the p210 epitope implicated in atherosclerosis immunotherapies.

Authors:  Josué I Beltrán-López; Andrea Romero-Maldonado; Elizabeth Monreal-Escalante; Bernardo Bañuelos-Hernández; Luz Mt Paz-Maldonado; Sergio Rosales-Mendoza
Journal:  Plant Cell Rep       Date:  2016-02-17       Impact factor: 4.570

Review 2.  Issues in vaccinology: Present challenges and future directions.

Authors:  Dylan Sheerin; Peter Jm Openshaw; Andrew J Pollard
Journal:  Eur J Immunol       Date:  2017-09-27       Impact factor: 5.532

3.  Quality vaccines for all people: Report on the 16th annual general meeting of the Developing Countries Vaccine Manufacturers' Network, 05-07th October 2015, Bangkok, Thailand.

Authors:  Sonia Pagliusi; Ching-Chia Ting; Sumana Khomvilai
Journal:  Vaccine       Date:  2016-03-03       Impact factor: 3.641

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.